[Asia Economy Reporter Lee Gwan-ju] Inbiogen announced on the 24th that it acquired 1,411,034 shares of Vident for approximately 13.8 billion KRW. This represents 17.73% of its equity capital, and the shareholding ratio after acquisition is 15.99%. The company stated that the purpose of the acquisition is "business diversification and strengthening management control."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
